LB Pharmaceuticals Inc Stock Price

NasdaqGM:LBRX Community·US$368.1m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

LBRX Share Price Performance

US$15.60

-1.70 (-9.83%)

US$15.60

-1.70 (-9.83%)

US$15.60

Sun, 19 Oct 25

Share PriceUS$15.60

LBRX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks

0 Rewards

View Full Analysis

LB Pharmaceuticals Inc Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -1.31
: 0%
: 0%
: 0%

View Full Analysis

About LBRX

Founded: 2015
Employees: 16
CEO: Heather Turner
WebsiteView website: lbpharma.us

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.